Credissential Provides Bi-Weekly Status Update On MCTO

Credissential Inc. (CSE: WHIP) said its Management Cease Trade Order (MCTO) granted Oct. 29 remains in place because its audited annual financial statements for the year ended June 30, 2025 have been delayed; the MCTO bars trading by the CEO and CFO while the company’s public shares remain freely tradable. Management attributes the delay to complex audit work stemming from the consolidation of two acquisitions, accounting for convertible note financings and an internal transition of day‑to‑day accounting to Cavalry Advisory Group that required additional reconciliations; auditor Kenway Mack Slusarchuk Stewart LLP has cited staffing and scheduling constraints but has committed to complete the audit by Dec. 31, 2025. Credissential has asked that the MCTO remain until filings are made, will continue biweekly NP 12‑203 status reports, and says there are no other undisclosed material changes, though timing and completion remain subject to audit and regulatory risk.

Analysis

Credissential Inc. (CSE: WHIP) reports its Management Cease Trade Order (MCTO), granted October 29, 2025, remains in effect because audited annual financial statements, MD&A and CEO/CFO certifications for the fiscal year ended June 30, 2025 are delayed. The MCTO prevents trading by the Chief Executive Officer and Chief Financial Officer while the company confirms its public shares remain freely tradable, and management will issue biweekly NP 12-203 status reports.

Management attributes the delay to complex audit procedures arising from the consolidation of two acquisitions and accounting for convertible note financings, plus an internal transition of day-to-day accounting to Cavalry Advisory Group that required additional reconciliatory work. The auditor, Kenway Mack Slusarchuk Stewart LLP (KMSS), cited staffing and scheduling constraints yet has committed to complete the audit on or before December 31, 2025, though no firm completion date has been received by the company.

The continued MCTO and timing uncertainty create governance and disclosure risk that the market prices negatively, consistent with the mildly negative sentiment signal; the primary near-term catalyst is the auditor meeting the December 31 deadline. A missed deadline or adverse audit outcomes (e.g., material adjustments to purchase price allocations, fair-value assessments or financial instrument accounting) would materially increase downside risk, so investors face an information-limited period until the filings are released.

Key Decisions for Investors

• Monitor Credissential's biweekly NP 12-203 status reports and the auditor's December 31, 2025 completion commitment closely, treat that date as the primary catalyst for directional change
• Avoid initiating new long positions or materially increasing exposure until the audited annual financial statements and MD&A are filed and reviewed
• If already invested, consider reducing position size or implementing hedges (for example, options or stop-loss orders) to limit downside while the MCTO and audit uncertainty persist
• Re-assess the investment after filings are released, focusing on purchase price allocations, fair-value assessments and convertible note accounting to evaluate potential balance-sheet dilution or impairment risk